TXMDTherapeuticsMD, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · therapeuticsmd.com

2.060USD+1.48%Mkt Cap: 23.84M $P/E: —3d ago

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap23.84M $

Enterprise Value20.21M $

Revenue (TTM)3.27M $

Gross Profit3.27M $

Net Income (TTM)-569.00K $

Revenue/Share0.2830 USD

Last Price2.060 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)5.89

PEG—

EV/EBITDA-14.77

EV/Revenue6.18

P/S7.29

P/B0.88

EPS (TTM)-0.03

EPS (Forward)0.35

52W Range

0.990055% of range2.950

52W High2.950 USD

52W Low0.9900 USD

Profitability

Gross Margin100.00%

Oper. Margin-32.22%

EBITDA Margin-41.87%

Profit Margin-18.83%

ROE-2.12%

ROA-1.51%

Growth

Revenue Growth-8.70%

Earnings Growth-80.60%

Cash Flow & Leverage

Operating CF2.45M $

CapEx (TTM)—

FCF Margin27.42%

FCF Yield3.76%

Net Debt-3.63M $

Net Debt/EBITDA2.65

Balance Sheet

Debt/Equity0.23

Current Ratio3.22

Quick Ratio2.65

Book Value/Sh2.330 USD

Cash/Share0.7940 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:50

Split DateMay 9, 2022

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.11.57M

Float9.49M

Insiders9.04%

Institutions31.80%

Short Interest

Short Ratio1.1d

Short % Float0.35%

Short % Out.0.25%

Shares Short29.14K

Short (prev mo.)56.55K

Technical

SMA 502.055 (+0.2%)

SMA 2002.025 (+1.7%)

Beta0.64

S&P 52W Chg18.16%

Avg Vol (30d)19.29K

Avg Vol (10d)22.95K

Technical Indicators

RSI (14)51.0

MACD0.0005

MACD Signal0.0028

MACD Hist.-0.0023

BB Upper2.099 USD

BB Middle2.058 USD

BB Lower2.016 USD

BB Width4.03%

ATR (14)0.0629 USD

Vol Ratio (20d)0.18x